Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,226	2,536	2,089	4,538	7,227	4,949
Market Cap Growth	-19.63%	21.37%	-53.96%	-37.21%	46.03%	-2.09%
Enterprise Value	2,097	2,417	1,962	4,398	7,047	4,776
Last Close Price	3.89	4.43	3.65	7.73	12.31	8.43

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Forward PE	-	14.24	14.24	14.24	14.24	14.24
PS Ratio	8.79	7.38	7.73	21.22	45.12	38.74
PB Ratio	2.36	2.54	2.02	3.58	4.71	2.72
P/TBV Ratio	2.57	2.71	2.18	3.84	4.99	2.96
P/FCF Ratio	-	-	27.47	436.96	-	-
P/OCF Ratio	59513.74	-	25.80	189.74	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	8.28	7.04	7.26	20.57	44.00	37.38
EV/FCF Ratio	-	-	25.80	423.52	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.00	0.00
Debt / EBITDA Ratio	-	0.41	-	-	-	-
Debt / FCF Ratio	-	-	0.16	1.80	-	-
Net Debt / Equity Ratio	-0.15	-0.16	-0.19	-0.12	-0.11	-0.11
Net Debt / EBITDA Ratio	1.77	159.33	1.44	1.58	0.99	1.18
Net Debt / FCF Ratio	15.02	4.98	-2.58	-14.85	5.09	1.07
Asset Turnover	0.24	0.31	0.21	0.15	0.09	0.06
Inventory Turnover	1.29	1.27	0.86	0.27	0.38	0.35
Quick Ratio	3.75	7.52	2.24	2.99	10.89	13.22
Current Ratio	7.04	14.76	4.96	9.23	37.56	40.25
Return on Equity (ROE)	-9.49%	-3.54%	-17.13%	-19.01%	-17.15%	-12.78%
Return on Assets (ROA)	-5.43%	-1.00%	-7.75%	-5.10%	-7.62%	-6.47%
Return on Invested Capital (ROIC)	-12.06%	-2.10%	-16.01%	-9.61%	-13.90%	-12.07%
Return on Capital Employed (ROCE)	-9.70%	-1.80%	-15.00%	-9.30%	-13.50%	-11.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-4.47%	-1.47%	-9.51%	-5.90%	-3.98%	-5.02%
FCF Yield	-0.41%	-1.30%	3.64%	0.23%	-0.45%	-3.75%
Buyback Yield / Dilution	6.17%	8.80%	-0.39%	0.77%	0.86%	-0.03%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error